Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-25 @ 9:51 PM
Study NCT ID:
NCT04991051
Status:
COMPLETED
Last Update Posted:
2024-02-06
First Post:
2021-07-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study to Determine the Prevalence of Homologous Recombination Deficiency Among Women With Newly Diagnosed, High-grade, Serous or Endometrioid Ovarian, Primary Peritoneal, and/or Fallopian Tube Cancer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-15
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-08
First Submit QC Date:
None
Study First Post Date:
2021-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-05
Last Update Post Date:
2024-02-06
Last Update Post Date Type:
ACTUAL